Authors: BODSWORTH NJ BOAG F BURDGE D GENEREUX M BORLEFFS JCC EVANS BA MODAI J COLEBUNDERS R THOMAS M DEHERTOGH D PACELLI L THOMIS J KNIGHT V MCNULTY AM DELANEY C VANHOVE D SACKS S GAGE L MCLEOD A DIAZMITOMA F FONG J MACFADDEN D MARTEL A RACHLIS A SALIT I SHAFRAN S SZABO J TOMA E DESCHENES L GILL J LALONDE R KAUFHOLD R MOLINA JM DELLAMONICA P ROZENBAUM W KOLSTERS FP MEENHORST PL DANNER S SPRENGER HG ELLISPEGLER RB MORAGAS J MOYLE G COLMAN J PARNELL A MCLEAN KA HOLMES DA KITCHEN V LINDE A DAHL H DWYER D

Citation: Nj. Bodsworth et al., EVALUATION OF SORIVUDINE (BV-ARAU) VERSUS ACYCLOVIR IN THE TREATMENT OF ACUTE LOCALIZED HERPES-ZOSTER IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED ADULTS, The Journal of infectious diseases, 176(1), 1997, pp. 103-111

Authors: PACELLI L BERETTA A BIONDA A SCAGNOL I SPECIALE L BRUCATO F PALMIERI G FERRANTE P

Citation: L. Pacelli et al., MODULATION OF CYTOKINES RELEASE FROM HUMAN ENDOTHELIAL-CELLS BY COUMARIN, Journal of experimental & clinical cancer research, 14(1), 1995, pp. 124-125

Authors: SCHINDZIELORZ A PIKE I DANIELS M PACELLI L SMALDONE L

Citation: A. Schindzielorz et al., RATES AND RISK-FACTORS FOR ADVERSE EVENTS ASSOCIATED WITH DIDANOSINE IN THE EXPANDED ACCESS PROGRAM, Clinical infectious diseases, 19(6), 1994, pp. 1076-1083